[Skip to Navigation]
January 1996

Neonatal Curettage of Giant Congenital Melanocytic Nevi

Arch Dermatol. 1996;132(1):20-22. doi:10.1001/archderm.1996.03890250022005

REPORT OF CASES  Four newborns presented with giant congenital melanocytic nevi (GCMN). Curettage was performed during the first weeks of life.

THERAPEUTIC CHALLENGE  Giant congenital melanocytic nevi may lead to severe cosmetic deformities and subsequent psychosocial problems for the child. Another important problem is the relatively high potential of GCMN to undergo malignant transformation.1-3 Management of such lesions presents an enormous challenge to those caring for these patients. The choice of surgical procedures depends on the consideration of the importance of the patient's cosmetic appearance, the reduction of the risk of malignancy, and the maintenance of normal function. Excision is the surest method of removing all potentially malignant cells. However, although great strides have been made in excisional surgery, particularly with the use of tissue expanders, all of the tumor cannot always be removed easily, and cosmetic results are sometimes less than satisfactory. Our challenge was to use a

Add or change institution